NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/13/2024
Back to search
Official data from USPTO
B
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000097648630Class
1, 5, 39, 40, 42
Filing
97648630
Registration
7476146
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
08/13/2024
Trademark type
Combined
Nice classes
1, 5, 39, 40, 42
Filing date
10/26/2022
Registration date
08/13/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/13/2024
Last transaction
08/13/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/01/2022
First use in commerce
09/01/2022
Drawing code
3
Owner type
03
Owner location
Staad, CH
Examiner
BECHHOFER, YOCHEVED
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized letter B with an angle design on the bottom left of the B.
Holders and representatives
Holders
Biosynth AG
Representatives
Tara Reedy Sliva DENTONS US LLP
Technical classification
Nice Classes
Class 1Class 5Class 39Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biochemicals and organic chemicals used as enzyme substratesenzyme inducersaminoglutethimidescarbamazepinesgriseofulvinsprimidonesenzyme inactivatorscultural medium additives for use in the field of microbiology and molecular biology; biochemical and organic chemical reagents for clinical diagnostic laboratory use; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology; Chemical reagents for medical laboratory analysis purposesfor use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms
Class 5
Medicinal preparationsphotosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical usefor the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposesfor Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosiscoronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposesfor novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Organic chemical preparations for medical purposesimmunomodulators with anti-inflammatory properties; Organic chemical preparations and enzymes for medical laboratory analysis purposesfor medical detectionidentification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposesfor medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposesfor medical detection of pathogenic bacteriavarious strains of ListeriaClostridiumBacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposesfor the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureusin particular for Methicillin-resistant Staphylococcus aureus (MRSA)
Class 39
Packaging and filling articles to the order and specification of others; Warehouse services
Class 40
Custom manufacture of medicines and diagnostics for others; Custom manufacturing for others in the pharmaceuticaldiagnosticveterinarybiotechnology and chemistry fields
Class 42
Quality management servicesquality evaluation and analysisquality assurancequality controlin the field of medicines and diagnostics
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/13/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/07/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/07/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/25/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/25/2024
IUAF
USE AMENDMENT FILED
04/26/2024
EISU
TEAS STATEMENT OF USE RECEIVED
04/26/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/14/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/19/2023
PUBO
PUBLISHED FOR OPPOSITION
09/19/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/30/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/11/2023
DOCK
ASSIGNED TO EXAMINER
08/09/2023
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/10/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/09/2022
NWAP
NEW APPLICATION ENTERED
10/29/2022
Continuous trademark protection
Get notified about every new filing that threatens B or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.